Table 4 Incidences of sequelae or persistent symptoms (SPS) after discharge
SPS | Exposed cohort (hospitalised due to COVID-19) (n = 453) | Non-exposed cohort (hospitalised due to other causes) (n = 453) | Risk ratio (95% CI)b |
|---|---|---|---|
N (Cumulative incidence)a | N (Cumulative incidence)a | ||
Any SPS | 120 (26.5) | 105 (23.2) | 1.14 (0.91 to 1.43) |
General/systemic SPS | 55 (12.1) | 63 (13.9) | 0.87 (0.62 to 1.22) |
Fatigue | 35 (7.7) | 40 (8.8) | 0.88 (0.57 to 1.35) |
Muscle weakness | 14 (3.1) | 8 (1.8) | 1.75 (0.74 to 4.27) |
Muscle or joint pain | 35 (7.7) | 30 (6.6) | 1.17 (0.73 to 1.87) |
Respiratory SPS | 77 (17.0) | 58 (12.8) | 1.33 (0.97 to 1.82) |
Dyspnoea | 60 (13.2) | 43 (9.5) | 1.40 (0.96 to 2.02) |
Chest pain | 4 (0.9) | 6 (1.3) | 0.67 (0.19 to 2.37) |
Pharyngeal symptoms | 16 (3.5) | 2 (0.4) | 8.00 (1.85 to 36.12) |
Neurological SPS | 40 (8.8) | 25 (5.5) | 1.60 (0.99 to 2.59) |
Headache | 9 (2.0) | 9 (2.0) | 1.00 (0.40 to 2.50) |
Sensitivity disorders | 8 (1.8) | 7 (1.5) | 1.14 (0.42 to 3.12) |
Movement disorders | 3 (0.7) | 1 (0.2) | 3.00 (0.30 to 28.70) |
Confusion, memory loss | 14 (3.1) | 4 (0.9) | 3.50 (1.16 to 10.55) |
Mental health SPS | 41 (9.1) | 35 (7.7) | 1.17 (0.76 to 1.80) |
Depressive symptoms | 18 (4.0) | 16 (3.5) | 1.13 (0.58 to 2.18) |
Anxiety symptoms | 33 (7.3) | 14 (3.1) | 2.36 (1.28 to 4.34) |
Sleep disturbances | 10 (2.2) | 7 (1.5) | 1.43 (0.55 to 3.81) |
Haematological SPS | 5 (1.1) | 4 (0.9) | 1.25 (0.34 to 4.62) |
Dermatological SPS | 8 (1.8) | 18 (4.0) | 0.46 (0.21 to 1.02) |
Nephrological SPS | 5 (1.1) | 2 (0.4) | 2.20 (0.50 to 9.76) |
Urological SPS | 5 (1.1) | 12 (2.6) | 0.44 (0.16 to 1.19) |
Otorhinolaryngological SPS | 4 (0.9) | 6 (1.3) | 0.69 (0.21 to 2.29) |
Ophthalmological SPS | 4 (0.9) | 14 (3.1) | 0.31 (0.11 to 0.89) |
Digestive SPS | 42 (9.3) | 45 (9.9) | 0.30 (0.14 to 0.63) |
Diarrhoea | 35 (7.7) | 33 (7.3) | 0.93 (0.63 to 1.39) |
Constipation | 6 (1.3) | 9 (2.0) | 0.68 (0.25 to 184) |
Abdominal pain | 12 (2.6) | 21 (4.6) | 0.58 (0.29 to 1.15) |
Infection | 7 (1.5) | 6 (1.3) | 1.15 (0.41 to 3.27) |